Celgene Continues Growing While Waiting for its Acquisition to Close

Celgene Continues Growing While Waiting for its Acquisition to Close

Source: 
Motley Fool
snippet: 

Celgene (NASDAQ: CELG) turned in a solid second quarter, allowing management to raise 2019 guidance as the company waits to be acquired by Bristol-Myers Squibb (NYSE: BMY).